The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTaylor Wimpey Regulatory News (TW.)

Share Price Information for Taylor Wimpey (TW.)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 144.50
Bid: 144.45
Ask: 144.60
Change: -2.45 (-1.67%)
Spread: 0.15 (0.104%)
Open: 145.10
High: 145.10
Low: 143.90
Prev. Close: 146.95
TW. Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

COVID-19 - Remuneration update

1 Apr 2020 07:00

RNS Number : 3133I
Taylor Wimpey PLC
01 April 2020
 

 

1 April 2020

Taylor Wimpey plc

 

Further update in response to COVID-19 - Application of Remuneration Policy in 2020

On 24 March 2020, Taylor Wimpey plc (the 'Company') announced a number of measures that were taken in response to the COVID-19 pandemic in the interest of the safety and wellbeing of our colleagues and customers. This included the temporary closure of all show homes, sales centres and construction sites.

In recognition of the impact of these measures on the Company's stakeholders and at the request of the Executive Directors, the Company's Remuneration Committee (the 'Committee') has carefully considered the proposed application of the Remuneration Policy in 2020.

The Committee has taken the decision to use its available discretion to amend the application of the Remuneration Policy for 2020 and we announce the following changes to the Executive Directors' remuneration for this year:

- The 2% annual salary increase due to come into effect on 1 April 2020 has been cancelled;

- The Executive Incentive Scheme (annual bonus) has been cancelled and there will be no cash bonus payable in respect of the Company's performance in 2020; and

- A voluntary 30% reduction in base salary and pension for the duration of the Government-imposed lockdown. In the event that the lockdown continues beyond 30 June 2020, the Remuneration Committee will review this particular matter again at that time.

The decision to take a reduction in base salary is supported by the whole Board and therefore the Non-Executive Directors will also take a 30% reduction in their fees for the same period of time. The objective of these changes is to conserve cash, with a particular focus on protecting the long term financial security of the business as a whole, for the benefit of all of the Company's stakeholders.

The Committee is not proposing any amendments to the Remuneration Policy which has been submitted to shareholders for approval at the Company's Annual General Meeting on 23 April 2020.

There will be full disclosure of the above measures in the 2020 Directors' Remuneration Report.

 

-Ends-

 

For further information please contact:

Taylor Wimpey plc Tel: +44 (0) 1494 885616

Alice Marsden, Group Company Secretary

Debbie Archibald, Investor Relations

 

Finsbury Tel: +44 (0) 20 7251 3801

Faeth Birch

Anjali Unnikrishnan

 

Notes to editors:

 

Taylor Wimpey plc is a customer-focused residential developer, operating at a local level from 24 regional businesses across the UK. We also have operations in Spain.

 

For further information, please visit the Group's website:

www.taylorwimpey.co.uk

 

Follow us on Twitter via @TaylorWimpeyplc

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDFZGFFNMGGGZM
Date   Source Headline
3rd Apr 201710:33 amRNSTotal Voting Rights
27th Mar 20174:24 pmRNSDirector/PDMR Shareholding
24th Mar 201711:29 amRNSDirector/PDMR Shareholding
17th Mar 201710:39 amRNSAnnual Financial Report
10th Mar 20179:22 amRNSDirector/PDMR Shareholding
6th Mar 20173:54 pmRNSDirector/PDMR Shareholding
1st Mar 20175:06 pmRNSDirector/PDMR Shareholding
1st Mar 201710:59 amRNSTotal Voting Rights
28th Feb 20177:00 amRNSFull year results for the year ended 31 Dec 2016
9th Feb 20173:26 pmRNSDirector/PDMR Shareholding
7th Feb 201710:06 amRNSDirectorate Change
1st Feb 20173:07 pmRNSTotal Voting Rights
11th Jan 20177:00 amRNSTrading statement for the year ended 31 Dec 2016
10th Jan 20173:17 pmRNSDirector/PDMR Shareholding
3rd Jan 20172:43 pmRNSBlock listing Interim Review
3rd Jan 20172:40 pmRNSBlock listing Interim Review
3rd Jan 20172:35 pmRNSTotal Voting Rights
12th Dec 20163:30 pmRNSDirector/PDMR Shareholding
1st Dec 20169:44 amRNSDirector/PDMR Shareholding
1st Dec 20169:39 amRNSTotal Voting Rights
23rd Nov 20167:38 amRNSAdditional Listing
14th Nov 20167:00 amRNSTrading statement
9th Nov 20164:04 pmRNSDirector/PDMR Shareholding
1st Nov 20169:57 amRNSTotal Voting Rights
1st Nov 20167:00 amRNSDirectorate Change
18th Oct 201610:18 amRNSDirector/PDMR Shareholding
11th Oct 20163:08 pmRNSDirector/PDMR Shareholding
6th Oct 20162:58 pmRNSDirector/PDMR Shareholding
3rd Oct 20167:00 amRNSTotal Voting Rights
9th Sep 20163:35 pmRNSDirector/PDMR Shareholding
1st Sep 20169:40 amRNSTotal Voting Rights
9th Aug 20164:41 pmRNSDirector/PDMR Shareholding
1st Aug 20169:07 amRNSTotal Voting Rights
27th Jul 20167:00 amRNSHalf year results for the period ended 3 July 2016
26th Jul 20162:40 pmRNSDirector/PDMR Shareholding
26th Jul 20167:00 amRNSHolding(s) in Company
11th Jul 20162:53 pmRNSDirector/PDMR Shareholding
1st Jul 201611:13 amRNSBlock listing Interim Review
1st Jul 201611:11 amRNSBlock listing Interim Review
1st Jul 20169:42 amRNSTotal Voting Rights
27th Jun 20168:27 amRNSDirector/PDMR Shareholding
24th Jun 20162:02 pmRNSDirector/PDMR Shareholding
14th Jun 20162:06 pmRNSTotal Voting Rights
10th Jun 20162:58 pmRNSDirector/PDMR Shareholding
3rd Jun 20161:51 pmRNSDirector/PDMR Shareholding
27th May 20167:00 amRNSDirectorate Change
26th May 20167:14 amRNSDirectorate Change
24th May 20161:00 pmRNSDirector/PDMR Shareholding
17th May 20167:00 amRNSAnalyst and Investor Day
11th May 20163:14 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.